Nicotinic acetylcholine receptor-based blockade: Applications of molecular targets for cancer therapy

Clinical Cancer Research

Volumn 17, Issue 11, 2011, Pages 3533-3541

  Wu, Chih Hsiung ^a,c   Lee, Chia Hwa ^b   Ho, Yuan Soon ^d,e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; ALPHA CONOTOXIN MII; ALPHA IMI; ALPHA IMII; ALPHA RGLA; BUNGAROTOXIN; DIHYDRO BETA ERYTHROIDINE; EPIGALLOCATECHIN GALLATE; ERYSODINE; GARCINOL; IT14A; LUTEOLIN; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; QUERCETIN; UNCLASSIFIED DRUG; VC1.1;

ANALGESIC ACTIVITY; ANGIOGENESIS; CARCINOGENESIS; CELL TRANSFORMATION; CIGARETTE SMOKING; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; HUMAN; METASTASIS; MOLECULARLY TARGETED THERAPY; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ACONITINE; ANTICARCINOGENIC AGENTS; CATECHIN; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION; SMOKING; TERPENES;

EID: 79957910370     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-2434     Document Type: Review

References (97)

1. Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S. Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 1994;79:705-15. (Pubitemid 24363813)
2. Lindstrom J. Nicotinic acetylcholine receptors in health and disease. Mol Neurobiol 1997;15:193-222. (Pubitemid 127719578)
3. Flores CM, DeCamp RM, Kilo S, Rogers SW, Hargreaves KM. Neuronal nicotinic receptor expression in sensory neurons of the rat trigeminal ganglion: demonstration of alpha3beta4, a novel subtype in the mammalian nervous system. J Neurosci 1996;16:7892-901. (Pubitemid 26405052)
4. Suzuki T, Hide I, Matsubara A, Hama C, Harada K, Miyano K, et al. Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. J Neurosci Res 2006;83:1461-70. (Pubitemid 43844991)
5. Ho YS, Chen CH, Wang YJ, Pestell RG, Albanese C, Chen RJ, et al. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation. Toxicol Appl Pharmacol 2005;205:133-48. (Pubitemid 40704648)
6. Chen RJ, Ho YS, Guo HR, Wang YJ. Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells. Toxicol Sci 2008;104:283-93.
7. Wei PL, Chang YJ, Ho YS, Lee CH, Yang YY, An J, et al. Tobacco-specific carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholine receptor. Ann Surg 2009;249:978-85.
8. Chen CS, Lee CH, Hsieh CD, Ho CT, Pan MH, Huang CS, et al. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins. Breast Cancer Res Treat 2011;125:73-87.
9. Lee CH, Chang YC, Chen CS, Tu SH, Wang YJ, Chen LC, et al. Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces alpha9-nicotinic acetylcholine receptor expression in human breast cancer cells. Breast Cancer Res Treat 2010.
10. Shih YL, Liu HC, Chen CS, Hsu CH, Pan MH, Chang HW, et al. Combination treatment with luteolin and quercetin enhances anti-proliferative effects in nicotine-treated MDA-MB-231 cells by downregulating nicotinic acetylcholine receptors. J Agric Food Chem 2010;58:235-41.
11. Arneric SP, Holladay M, Williams M. Neuronal nicotinic receptors: a perspective on two decades of drug discovery research. Biochem Pharmacol 2007;74:1092-101. (Pubitemid 47417924)
12. Broide RS, Leslie FM. The alpha7 nicotinic acetylcholine receptor in neuronal plasticity. Mol Neurobiol 1999;20:1-16.
13. Fayuk D, Yakel JL. Dendritic Ca2+ signalling due to activation of alpha 7-containing nicotinic acetylcholine receptors in rat hippocampal neurons. J Physiol 2007;582:597-611. (Pubitemid 47040547)
14. Fucile S. Ca2+ permeability of nicotinic acetylcholine receptors. Cell Calcium 2004;35:1-8. (Pubitemid 38054783)
15. Minna JD. Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. J Clin Invest 2003;111:31-3. (Pubitemid 36134845)
16. Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001;7:833-9. (Pubitemid 32691639)
17. Heeschen C, Weis M, Aicher A, Dimmeler S, Cooke JP. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 2002;110:527-36. (Pubitemid 34919707)
18. Cooke JP, Bitterman H. Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann Med 2004;36:33-40. (Pubitemid 38230697)
19. Dasgupta P, Kinkade R, Joshi B, Decook C, Haura E, Chellappan S. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci U S A 2006;103:6332-7.
20. Egleton RD, Brown KC, Dasgupta P. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases. Pharmacol Ther 2009;121:205-23.
21. Changeux JP, Kasai M, Lee CY. Use of a snake venom toxin to characterize the cholinergic receptor protein. Proc Natl Acad Sci USA 1970;67:1241-7.
22. Ishii M, Kurachi Y. Muscarinic acetylcholine receptors. Curr Pharm Des 2006;12:3573-81. (Pubitemid 44509627)
23. Changeux J, Edelstein SJ. Allosteric mechanisms in normal and pathological nicotinic acetylcholine receptors. Curr Opin Neurobiol 2001;11:369-77. (Pubitemid 32524104)
24. Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 2007;47:699-729.
25. Changeux JP, Bertrand D, Corringer PJ, Dehaene S, Edelstein S, Léna C, et al. Brain nicotinic receptors: structure and regulation, role in learning and reinforcement. Brain Res Brain Res Rev 1998;26:198-216. (Pubitemid 28318076)
26. McGehee DS, Heath MJ, Gelber S, Devay P, Role LW. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 1995;269:1692-6.
27. Schuller HM. Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosamines. Biochem Pharmacol 1989;38:3439-42. (Pubitemid 19250194)
28. Lee CH, Huang CS, Chen CS, Tu SH, Wang YJ, Chang YJ, et al. Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells. J Natl Cancer Inst 2010;102:1322-35.
29. Cooke JP. Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor. Life Sci 2007;80:2347-51. (Pubitemid 46818276)
30. Paliwal A, Vaissiére T, Krais A, Cuenin C, Cros MP, Zaridze D, et al. Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer. Cancer Res 2010;70:2779-88.
31. Jain RK, Finn AV, Kolodgie FD, Gold HK, Virmani R. Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization. Nat Clin Pract Cardiovasc Med 2007;4:491-502. (Pubitemid 47316647)
32. Yu J, Huang NF, Wilson KD, Velotta JB, Huang M, Li Z, et al. nAChRs mediate human embryonic stem cell-derived endothelial cells: proliferation, apoptosis, and angiogenesis. PLoS ONE 2009;4:e7040.
33. Glidewell-Kenney C, Weiss J, Lee EJ, Pillai S, Ishikawa T, Ariazi EA, et al. ERE-independent ERalpha target genes differentially expressed in human breast tumors. Mol Cell Endocrinol 2005;245:53-9.
34. Lustig LR, Peng H. Chromosome location and characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) gene. Cytogenet Genome Res 2002;98:154-9.
35. Lin RK, Hsieh YS, Lin P, Hsu HS, Chen CY, Tang YA, et al. The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest 2010;120:521-32.
36. Hecht SS, Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 1988;9:875-84.
37. Mei J, Hu H, McEntee M, Plummer H 3rd, Song P, Wang HC. Transformation of non-cancerous human breast epithelial cell line MCF10A by the tobacco-specific carcinogen NNK. Breast Cancer Res Treat 2003;79:95-105. (Pubitemid 36561047)
38. Chen RJ, Ho YS, Guo HR, Wang YJ. Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells. Toxicol Sci 2010;115:118-30.
39. Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, Ali M, et al. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS ONE 2009;4:e4849.
40. Sastry BV, Chance MB, Singh G, Horn JL, Janson VE. Distribution and retention of nicotine and its metabolite, cotinine, in the rat as a function of time. Pharmacology 1995;50:128-36.
41. Nishioka T, Guo J, Yamamoto D, Chen L, Huppi P, Chen CY. Nicotine, through upregulating pro-survival signaling, cooperates with NNK to promote transformation. J Cell Biochem 2010;109:152-61.
42. Schuller HM. Nitrosamines as nicotinic receptor ligands. Life Sci 2007;80:2274-80. (Pubitemid 46818287)
43. Davis R, Rizwani W, Banerjee S, Kovacs M, Haura E, Coppola D, et al. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS ONE 2009;4:e7524.
44. Cohen G, Han ZY, Grailhe R, Gallego J, Gaultier C, Changeux JP, et al. Beta 2 nicotinic acetylcholine receptor subunit modulates protective responses to stress: a receptor basis for sleep-disordered breathing after nicotine exposure. Proc Natl Acad Sci U S A 2002;99:13272-7.
45. Wüllner U, Gündisch D, Herzog H, Minnerop M, Joe A, Warnecke M, et al. Smoking upregulates alpha4beta2* nicotinic acetylcholine receptors in the human brain. Neurosci Lett 2008;430:34-7.
46. Glowatzki E, Fuchs PA. Cholinergic synaptic inhibition of inner hair cells in the neonatal mammalian cochlea. Science 2000;288:2366-8. (Pubitemid 30448161)
47. Nguyen VT, Ndoye A, Grando SA. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. Am J Pathol 2000;157:1377-91.
48. Luebke AE, Maroni PD, Guth SM, Lysakowski A. Alpha-9 nicotinic acetylcholine receptor immunoreactivity in the rodent vestibular labyrinth. J Comp Neurol 2005;492:323-33. (Pubitemid 41547319)
49. Vincler M, Wittenauer S, Parker R, Ellison M, Olivera BM, McIntosh JM. Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors. Proc Natl Acad Sci USA 2006;103:17880-4. (Pubitemid 44852254)
50. Kwon HM, Sangiorgi G, Ritman EL, McKenna C, Holmes DR Jr, Schwartz RS, et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 1998;101:1551-6. (Pubitemid 28198482)
51. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
52. Pontieri FE, Tanda G, Orzi F, Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996;382:255-7. (Pubitemid 26251360)
53. Mousa S, Mousa SA. Cellular and molecular mechanisms of nicotine's pro-angiogenesis activity and its potential impact on cancer. J Cell Biochem 2006;97:1370-8.
54. Li S, Zhao T, Xin H, Ye LH, Zhang X, Tanaka H, et al. Nicotinic acetylcholine receptor alpha7 subunit mediates migration of vascular smooth muscle cells toward nicotine. J Pharmacol Sci 2004;94:334-8. (Pubitemid 38470744)
55. Ye YN, Liu ES, Shin VY, Wu WK, Luo JC, Cho CH. Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J Pharmacol Exp Ther 2004;308:66-72.
56. Carlisle DL, Liu X, Hopkins TM, Swick MC, Dhir R, Siegfried JM. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells. Pulm Pharmacol Ther 2007;20:629-41. (Pubitemid 47446337)
57. Guo J, Ibaragi S, Zhu T, Luo LY, Hu GF, Huppi PS, et al. Nicotine promotes mammary tumor migration via a signaling cascade involving protein kinase C and CDC42. Cancer Res 2008;68:8473-81.
58. Horwitz AR, Parsons JT. Cell migration - movin' on. Science 1999;286:1102-3.
59. Sahai E. Mechanisms of cancer cell invasion. Curr Opin Genet Dev 2005;15:87-96. (Pubitemid 40127636)
60. Xu L, Deng X. Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and m-calpains. J Biol Chem 2006;281:4457-66. (Pubitemid 43847877)
61. Xu L, Deng X. Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of mu- and m-calpains. J Biol Chem 2006;281:35567-75. (Pubitemid 46036590)
62. Song LJ, Pan LJ, Xu YM. [Cavernous nerve reconstruction to restore erectile function following radical prostatectomy]. Zhonghua Nan Ke Xue 2006;12:939-42.
63. Andreasen JT, Henningsen K, Bate S, Christiansen S, Wiborg O. Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline. J Psychopharmacol 2010 [Epub ahead of print].
64. Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, Van Der Oost J, Smit AB, et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 2001;411:269-76. (Pubitemid 32467026)
65. Hansen SB, Taylor P. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors. J Mol Biol 2007;369:895-901. (Pubitemid 46754061)
66. Taly A, Corringer PJ, Guedin D, Lestage P, Changeux JP. Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov 2009;8:733-50.
67. Yu WF, Guan ZZ, Bogdanovic N, Nordberg A. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques. Exp Neurol 2005;192:215-25. (Pubitemid 40208555)
68. Luetje CW, Wada K, Rogers S, Abramson SN, Tsuji K, Heinemann S, et al. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. J Neurochem 1990;55:632-40. (Pubitemid 120021639)
69. Higgins LS, Berg DK. A desensitized form of neuronal acetylcholine receptor detected by 3H-nicotine binding on bovine adrenal chromaffin cells. J Neurosci 1988;8:1436-46.
70. Shen WX, Jobling P, Horn JP. The sensitivity of nicotinic synapses in bullfrog sympathetic ganglia to alpha-bungarotoxin and neuronalbungarotoxin. Br J Pharmacol 1994;113:898-902. (Pubitemid 24326831)
71. Davis JA, Gould TJ. The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice. Psychopharmacology (Berl) 2006;184:345-52. (Pubitemid 43255851)
72. Cui L, Thuong PT, Fomum ZT, Oh WK. A new Erythrinan alkaloid from the seed of Erythrina addisoniae. Arch Pharm Res 2009;32:325-8.
73. Holladay MW, Dart MJ, Lynch JK. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J Med Chem 1997;40:4169-94. (Pubitemid 28042300)
74. Sciamanna MA, Griesmann GE, Williams CL, Lennon VA. Nicotinic acetylcholine receptors of muscle and neuronal (alpha7) types coexpressed in a small cell lung carcinoma. J Neurochem 1997;69:2302-11. (Pubitemid 27495415)
75. Gotti C, Guiducci S, Tedesco V, Corbioli S, Zanetti L, Moretti M, et al. Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. J Neurosci 2010;30:5311-25.
76. Ullian EM, McIntosh JM, Sargent PB. Rapid synaptic transmission in the avian ciliary ganglion is mediated by two distinct classes of nicotinic receptors. J Neurosci 1997;17:7210-9. (Pubitemid 27413252)
77. Sandall DW, Satkunanathan N, Keays DA, Polidano MA, Liping X, Pham V, et al. A novel alpha-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo. Biochemistry 2003;42:6904-11. (Pubitemid 36666131)
78. Matsubayashi H, Inoue A, Amano T, Seki T, Nakata Y, Sasa M, et al. Involvement of alpha7- and alpha4beta2-type postsynaptic nicotinic acetylcholine receptors in nicotine-induced excitation of dopaminergic neurons in the substantia nigra: a patch clamp and single-cell PCR study using acutely dissociated nigral neurons. Brain Res Mol Brain Res 2004;129:1-7. (Pubitemid 39304244)
79. Wang Y, Su DM, Wang RH, Liu Y, Wang H. Antinociceptive effects of choline against acute and inflammatory pain. Neuroscience 2005;132:49-56. (Pubitemid 40380713)
80. Uteshev VV, Meyer EM, Papke RL. Activation and inhibition of native neuronal alpha-bungarotoxin-sensitive nicotinic ACh receptors. Brain Res 2002;948:33-46. (Pubitemid 35283759)
81. Dasgupta P, Chellappan SP. Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle 2006;5:2324-8. (Pubitemid 44801377)
82. Heeschen C, Weis M, Cooke JP. Nicotine promotes arteriogenesis. J Am Coll Cardiol 2003;41:489-96. (Pubitemid 36164508)
83. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003;111:81-90. (Pubitemid 36134851)
84. Gilbert SD, Clark TM, Flores CM. Antihyperalgesic activity of epibatidine in the formalin model of facial pain. Pain 2001;89:159-65. (Pubitemid 32146394)
85. Lippiello PM, Beaver JS, Gatto GJ, James JW, Jordan KG, Traina VM, et al. TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity. CNS Neurosci Ther 2008;14:266-77.
86. Glover ED, Laflin MT, Schuh KJ, Schuh LM, Nides M, Christen AG, et al. A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers. Addiction 2007;102:795-802. (Pubitemid 46633360)
87. Sun D, Ren Z, Zeng X, You Y, Pan W, Zhou M, et al. Structure-function relationship of conotoxin lt14a, a potential analgesic with low cytotoxicity. Peptides 2011;32:300-5.
88. Peng C, Tang S, Pi C, Liu J, Wang F, Wang L, et al. Discovery of a novel class of conotoxin from Conus litteratus, lt14a, with a unique cysteine pattern. Peptides 2006;27:2174-81. (Pubitemid 44209293)
89. McIntosh JM, Plazas PV, Watkins M, Gomez-Casati ME, Olivera BM, Elgoyhen AB. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors. J Biol Chem 2005;280:30107-12. (Pubitemid 41216187)
90. Ellison M, Feng ZP, Park AJ, Zhang X, Olivera BM, McIntosh JM, et al. Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues. J Mol Biol 2008;377:1216-27.
91. Ellison M, Gao F, Wang HL, Sine SM, McIntosh JM, Olivera BM. Alpha-conotoxins ImI and ImII target distinct regions of the human alpha7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes. Biochemistry 2004;43:16019-26. (Pubitemid 40041015)
92. Livett BG, Sandall DW, Keays D, Down J, Gayler KR, Satkunanathan N, et al. Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor. Toxicon 2006;48:810-29. (Pubitemid 44738988)
93. Tu SH, Ku CY, Ho CT, Chen CS, Huang CS, Lee CH, et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen- induced alpha9-nicotinic acetylcholine receptor upregulation in human breast cancer cells. Mol Nutr Food Res 2010 [Epub ahead of print].
94. Jarzynka MJ, Guo P, Bar-Joseph I, Hu B, Cheng SY. Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis. Int J Oncol 2006;28:337-44.
95. Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, Christie N, et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res 2002;62:2141-50. (Pubitemid 34408463)
96. Hershberger PA, Vasquez AC, Kanterewicz B, Land S, Siegfried JM, Nichols M. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res 2005;65:1598-605. (Pubitemid 40270190)
97. Stabile LP, Lyker JS, Gubish CT, Zhang W, Grandis JR, Siegfried JM. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res 2005;65:1459-70. (Pubitemid 40270175)